Contraception: Clinical Trials

86 trials for Contraception, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

64 completed, 10 unknown, 6 terminated, 3 recruiting. 86 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 486Completed 64, Unknown 10, Terminated 6, Recruiting 3, Active not recruiting 1, Suspended 1, Withdrawn 1

Follow Contraception: new trials by email Literature Review of Contraception trials Research Report on Contraception

Trials (filtered) newest first · largest first

All 86 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oral Contraceptive Pill (OCP) Pharmacogenomics
Desogestrel / Ethinyl Estradiol Pill - Contraception, Pharmacogenomic Drug Interaction
Phase 4RecruitingYale University7002024-10-292026-07-16
Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement
Ketorolac, Placebo - IUD, Healthy Female
Phase 4UnknownArkansas Children's Hospital Research Institute182024-02-052024-07-31
A Multicentre, Prospective, Open-label, Non-comparative Study
Female Contraceptive - Contraception
Phase 4UnknownItalfarmaco2282023-07-202023-10-04
Patient-Applied Pretreatment Analgesia for Intrauterine Device Placement
Lidocaine topical, Tampon - Contraception
Phase 4UnknownUniformed Services University of the Health Sciences1202023-06-012023-06-06
Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start
Levonorgestrel 52 MG Intrauterine System - Contraception
Phase 4RecruitingUniversity of Utah14042022-11-072026-04-16
Continuation of Subcutaneous and Intramuscular Depot Medroxyprogesterone Acetate in Post-abortion Patients
Depot-Medroxyprogestereone Acetate - Contraception
Phase 4CompletedNorthwestern University2632022-08-012026-10-15
Metabolism of 0.35mg Norethindrone vs 5mg Norethindrone Acetate
Norethindrone Acetate 5 MG, Norethindrone 0.35 MG - Contraception
Phase 4CompletedMilton S. Hershey Medical Center62022-07-222024-07-16
Etonogestrel Implant as Emergency Contraception
Etonogestrel implant - Contraception
Phase 4RecruitingUniversity of Colorado, Denver122022-04-012026-08-11
A Study to Assess the Safety of a New Inserter Device for Paragard® (Intrauterine Copper Contraceptive)
Paragard® T380A Intrauterine Copper Contraceptive with New Inserter - Contraception
Phase 4CompletedCooperSurgical Inc.1192022-03-042026-08-25
Evaluation of Pharmacokinetic Drug-drug Interactions Between Hormonal Contraceptives and Doravirine-containing ART Among Women Living With HIV in South Africa
Etonogestrel (ETG) implant, Intramuscular depo-medroxyprogesterone acetate (IM DMPA), Sub-cutaneous medroxyprogesterone acetate (SC MPA) - HIV Infections, Contraception
Phase 4CompletedUniversity of Alabama at Birmingham1102021-11-172025-04-08
Progestin-Only Pill Use and Breastfeeding Study
Progestin Only Contraceptive Pills - Contraception, Breastfeeding
Phase 4CompletedUniversity of California, San Diego302021-10-252024-04-19
Investigating the Interaction Between Two Long-acting Reversible Methods of Contraception and Dolutegravir, a Treatment for HIV
Dolutegravir, Levonorgestrel implant, Depo medroxyprogesterone acetate injection - Human Immunodeficiency Virus, Contraception
Phase 4UnknownBotswana Harvard AIDS Institute Partnership1402021-10-212023-07-27
Desogestrel-containing COCP Pharmacokinetic Validation Study
Desogestrel and Ethinyl Estradiol Tablets - Contraception
Phase 4CompletedUniversity of Colorado, Denver222021-09-102025-05-30
PrEParing Family Planning Clinics to Streamline Integration of HIV Prevention Services for Young Women in Kenya
PrEP - HIV Infections, Contraception
Phase 4CompletedUniversity of Washington254572021-03-012025-09-04
Effects of a Progestin on Frequent and/or Prolonged Bleeding With Nexplanon™
Norethindrone acetate (NTA), Placebo - Birth Control, Contraception
Phase 4TerminatedBaylor Research Institute512021-02-112024-02-02
Uterovaginal Plexus Block With Articaine for Intrauterine Device Placement Patients Who Are Indicated for the Use of Copper IUD as a Contraceptive Method Will be Invited to Participate in This Research.
Articaine Hydrochloride 40 MG/ML, Mepivacaine - Contraception, IUD
Phase 4UnknownUniversidade do Vale do Sapucai2402021-02-012022-02-23
RCT Evaluating Standardized Counseling on Early Discontinuation for Irregular Bleeding in Nexplanon Users
Additional Standardized Counseling - Birth Control, Contraception
Phase 4Active not recruitingPlanned Parenthood of the St. Louis Region and Southwest Missouri3482020-11-242025-06-04
Shoulder Contraceptive Implant Study
Etonogestrel implant - Contraception
Phase 4CompletedUniversity of Colorado, Denver52020-10-142023-06-08
Rifampin and the Contraceptive Implant
Rifampin 600 MG - Contraception, Tuberculosis
Phase 4CompletedUniversity of Colorado, Denver242020-09-232023-05-16
Nexplanon Use in Women Primarily Choosing a Combined Oral Contraceptive
Etonogestrel contraceptive implant - Contraception
Phase 4CompletedUniversity of California, Davis1202020-08-132024-05-22

Showing 20 of 86. Sign in to see all of them.

Narrower conditions

Body Weight (3)  ·  Breast Feeding (2)  ·  HIV Infections (2)  ·  Sexually Transmitted Diseases (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Behavior (1)  ·  Contraception Behavior (1)  ·  Depression, Postpartum (1)  ·  Epilepsy (1)  ·  Hemorrhage (1)  ·  Insulin Resistance (1)  ·  Menorrhagia (1)  ·  Metrorrhagia (1)  ·  Obesity (1)  ·  Risk Reduction Behavior (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (8)  ·  Urogenital Diseases (7)  ·  Genital Diseases (6)  ·  Infections (5)  ·  Pathologic Processes (5)  ·  Communicable Diseases (4)  ·  Behavior (3)  ·  Blood-Borne Infections (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Immune System Diseases (3)  ·  Immunologic Deficiency Syndromes (3)  ·  Lentivirus Infections (3)  ·  RNA Virus Infections (3)  ·  Retroviridae Infections (3)  ·  Sexually Transmitted Diseases, Viral (3)

Interventions

Levonorgestrel (15)  ·  Ethinyl Estradiol (10)  ·  etonogestrel (10)  ·  Medroxyprogesterone Acetate (6)  ·  Contraceptives, Oral (4)  ·  ulipristal acetate (4)  ·  Ethinyl Estradiol-Norgestrel Combination (3)  ·  Intrauterine Devices (3)  ·  N,N-dimethyl-4-anisidine (3)  ·  Norethindrone (3)  ·  NuvaRing (3)  ·  Contraception, Postcoital (2)  ·  Contraceptive Agents (2)  ·  Desogestrel (2)  ·  Estradiol (2)

Sponsors

Oregon Health and Science University (9)  ·  Bayer (4)  ·  University of Colorado, Denver (4)  ·  University of Sao Paulo (4)  ·  University of Utah (4)  ·  Columbia University (3)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (3)  ·  Organon and Co (3)  ·  Cairo University (2)  ·  Mahidol University (2)  ·  Pfizer (2)  ·  University of California, Davis (2)  ·  University of North Carolina, Chapel Hill (2)  ·  University of Pittsburgh (2)  ·  University of Washington (2)

Countries

United States (51)  ·  Brazil (7)  ·  France (4)  ·  Canada (2)  ·  Finland (2)  ·  Mexico (2)  ·  Botswana (1)  ·  China (1)  ·  Ireland (1)  ·  Italy (1)  ·  Kenya (1)  ·  Malawi (1)  ·  Russia (1)  ·  South Africa (1)  ·  Spain (1)

Top investigators

Carolina S Vieira, MD, PhD (3)  ·  Alison Edelman, MD, MPH (2)  ·  Aaron M Lazorwitz, MD, PhD (1)  ·  Alison Edelman, MD (1)  ·  Angelo Cagnacci, MD (1)  ·  Anita L Nelson, MD (1)  ·  Anna Wald, MD, MPH (1)  ·  Anne Burke, MD MPH (1)  ·  Anne Davis, MD (1)  ·  Anne Davis, MD MPH (1)  ·  Annina Haverinen, MD, PhD student (1)  ·  Athena P Kourtis, MD, PhD, MPH (1)

Results publications

PMID 16102549, PMID 16394049, PMID 17067996, PMID 17540797, PMID 17714677, PMID 18238962, PMID 18313637, PMID 18360319, PMID 18395692, PMID 18468575, PMID 18685543, PMID 18976753, PMID 19245303, PMID 19935020, PMID 19955104, PMID 20378611, PMID 20472114, PMID 21514555, PMID 21651392, PMID 21843690, PMID 21860292, PMID 22920273, PMID 24560483, PMID 24682613, PMID 25487172, PMID 26942358, PMID 27000996, PMID 27406214, PMID 27554014, PMID 27607859, PMID 28594758, PMID 28692531, PMID 29201430, PMID 29457758, PMID 29470950, PMID 29496473, PMID 29746813, PMID 29750924, PMID 29920171, PMID 30529085, PMID 31145885, PMID 31299074, PMID 31374188, PMID 31950432, PMID 32303765, PMID 32591417, PMID 33478494, PMID 33503342, PMID 33706343, PMID 34259467

NIH funding

2005 (1), 2017 (1), K01TW009657 (1), K23HD078153 (1), R01HD111436 (1), R01MH123267 (1), R21AT002297 (1), U48DP001944 (1), U54HD042454 (1)